Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 8 de 8
1.
BJOG ; 122(1): 80-91, 2015 Jan.
Article En | MEDLINE | ID: mdl-25209926

OBJECTIVE: To evaluate the effectiveness of 200 mg of daily vaginal natural progesterone to prevent preterm birth in women with preterm labour. DESIGN: Multicentre, randomised, double-blind, placebo-controlled trial. SETTING: Twenty-nine centres in Switzerland and Argentina. POPULATION: A total of 385 women with preterm labour (24(0/7) to 33(6/7) weeks of gestation) treated with acute tocolysis. METHODS: Participants were randomly allocated to either 200 mg daily of self-administered vaginal progesterone or placebo within 48 hours of starting acute tocolysis. MAIN OUTCOME MEASURES: Primary outcome was delivery before 37 weeks of gestation. Secondary outcomes were delivery before 32 and 34 weeks, adverse effects, duration of tocolysis, re-admissions for preterm labour, length of hospital stay, and neonatal morbidity and mortality. The study was ended prematurely based on results of the intermediate analysis. RESULTS: Preterm birth occurred in 42.5% of women in the progesterone group versus 35.5% in the placebo group (relative risk [RR] 1.2; 95% confidence interval [95% CI] 0.93-1.5). Delivery at <32 and <34 weeks did not differ between the two groups (12.9 versus 9.7%; [RR 1.3; 95% CI 0.7-2.5] and 19.7 versus 12.9% [RR 1.5; 95% CI 0.9-2.4], respectively). The duration of tocolysis, hospitalisation, and recurrence of preterm labour were comparable between groups. Neonatal morbidity occurred in 44 (22.8%) cases on progesterone versus 35 (18.8%) cases on placebo (RR: 1.2; 95% CI 0.82-1.8), whereas there were 4 (2%) neonatal deaths in each study group. CONCLUSION: There is no evidence that the daily administration of 200 mg vaginal progesterone decreases preterm birth or improves neonatal outcome in women with preterm labour.


Birth Weight , Obstetric Labor, Premature/drug therapy , Premature Birth/prevention & control , Progesterone/therapeutic use , Progestins/therapeutic use , Administration, Intravaginal , Adult , Apgar Score , Double-Blind Method , Female , Humans , Indomethacin/therapeutic use , Infant , Infant Mortality , Infant, Newborn , Intensive Care Units, Neonatal/statistics & numerical data , Pregnancy , Pregnancy Trimester, Second , Pregnancy Trimester, Third , Receptors, Oxytocin/antagonists & inhibitors , Tocolytic Agents/therapeutic use , Young Adult
2.
BJOG ; 120(13): 1685-94; discussion 1944-5, 2013 Dec.
Article En | MEDLINE | ID: mdl-23937774

OBJECTIVE: To analyse life-threatening obstetric complications that occurred in public hospitals in Argentina. DESIGN: Multicentre collaborative cross-sectional study. SETTING: Twenty-five hospitals included in the Perinatal Network of Buenos Aires Metropolitan Area. POPULATION: Women giving birth in participating hospitals during a 1-year period. METHODS: All cases of severe maternal morbidity (SMM) and maternal mortality (MM) during pregnancy (including miscarriage and induced abortion), labour and puerperium were included. Data were collected prospectively. MAIN OUTCOME MEASURES: Identification criteria, main causes and incidence of SMM; case-fatality rates, morbidity-mortality index and effective intervention's use rate. RESULTS: A total of 552 women with life-threatening conditions were identified: 518 with SMM, 34 with MM. Identification criteria for SMM were case-management (48.9%), organ dysfunction (15.2%) and mixed criteria (35.9%). Incidence of SMM was 0.8% (95% confidence interval [95% CI] 0.73-0.87%) and hospital maternal death ratio was 52.3 per 100 000 live births (95% CI 35.5-69.1). Main causes of MM were abortion complications and puerperal sepsis; main causes of SMM were postpartum haemorrhage and hypertension. Overall case-fatality rate was 6.2% (95% CI 4.4-8.6): the highest due to sepsis (14.8%) and abortion complications (13.3%). Morbidity-mortality index was 15:1 (95% CI 7.5-30.8). Use rate of known effective interventions to prevent or treat main causes of MM and SMM was 52.3% (95% CI 46.9-57.7). CONCLUSIONS: This study describes the importance of life-threatening obstetric complications that took place in public hospitals with comprehensive obstetric care and the low utilisation of known effective interventions that may decrease rates of SMM and MM. It also provides arguments that justify the need to develop a surveillance system for SMM.


Maternal Mortality , Pregnancy Complications/epidemiology , Puerperal Disorders/epidemiology , Abortion, Incomplete/therapy , Abortion, Induced/adverse effects , Abortion, Induced/mortality , Adult , Antibiotic Prophylaxis , Anticonvulsants/therapeutic use , Argentina , Cross-Sectional Studies , Female , Hospitals, Public , Humans , Magnesium Sulfate/therapeutic use , Pregnancy , Prospective Studies , Sepsis/mortality , Vacuum Curettage , Young Adult
7.
Obstet. ginecol. latinoam ; 44(5/6): 192-204, mayo-jun. 1986. ilus, tab
Article Es | LILACS | ID: lil-46993

Fueron analizados 200 registros cardiotocográficos de pacientes en trabajo de parto, que reunían exigencias de normalidad en el mismo, como así también en los resultados perinatales. Se valoraron exhaustivamente las diferencias encontradas entre los dos primeros períodos del trabajo de parto y se hallaron diferencias estadísticamente significativas tanto en la frecuencia de la línea de base, que se torna braquicárdica (entendiendo como tal a una definición del período dilatante), como así también de la variabilidad que muestra un aumento, producido por la mayor dispersión de latidos considerados clásicamente como patológicos. Es importante también la diferencia significativa, en la aparición de desaceleraciones en el período expulsivo, en especial de descensos variables que no demostraron patología en el producto. Todo esto, nos lleva a la conclusión de no poder clasificar a los distintos patrones cardiotográficos observados en el período expulsivo como anormales teniendo en cuenta los patrones clásicos del dilatante y evitar así adoptar por aquéllos una conducta obstétrica inadecuada


Pregnancy , Humans , Female , Heart Rate , Labor Stage, Second , Fetal Monitoring/methods
8.
Obstet. ginecol. latinoam ; 44(5/6): 192-204, mayo-jun. 1986. ilus, Tab
Article Es | BINACIS | ID: bin-31087

Fueron analizados 200 registros cardiotocográficos de pacientes en trabajo de parto, que reunían exigencias de normalidad en el mismo, como así también en los resultados perinatales. Se valoraron exhaustivamente las diferencias encontradas entre los dos primeros períodos del trabajo de parto y se hallaron diferencias estadísticamente significativas tanto en la frecuencia de la línea de base, que se torna braquicárdica (entendiendo como tal a una definición del período dilatante), como así también de la variabilidad que muestra un aumento, producido por la mayor dispersión de latidos considerados clásicamente como patológicos. Es importante también la diferencia significativa, en la aparición de desaceleraciones en el período expulsivo, en especial de descensos variables que no demostraron patología en el producto. Todo esto, nos lleva a la conclusión de no poder clasificar a los distintos patrones cardiotográficos observados en el período expulsivo como anormales teniendo en cuenta los patrones clásicos del dilatante y evitar así adoptar por aquéllos una conducta obstétrica inadecuada (AU)


Pregnancy , Humans , Female , Labor Stage, Second , Fetal Monitoring/methods , Heart Rate
...